Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.

Friday, September 14, 2007 General News J E 4
SCOTTSDALE, Ariz., Sept. 13 Partners Rx Management, LLC(PRx) is pleased to announce that Mr. Richard Bullard, PRx Chief PharmacyOfficer, has been invited to participate in a Panel Discussion on FormularyDesign and Development -- The Process at the Fall 2007 Managed Markets Summit(MMS) presented by Pinsonault Associates, LLC. MMS takes place September 25 -27, 2007 at the Point Hilton Tapatio Cliffs Hotel -- Phoenix, Arizona.

The panel discussion will cover the use of Pharmacoeconomic Data, the roleof AMCP Dossiers in the evaluation process and the consideration of otherexternal and financial factors that impact decisions. Also being discussed bythe panel are decision making strategies, adoption and communicationstrategies, and strategies to cope with emotional influences.

Mr. Bullard is responsible for the clinical oversight of PRx's pharmacybenefit management programs. He leads the development of clinical programs toimprove member health through an integrated approach to health care. Mr.Bullard ensures that PRx's clinical programs capitalize on innovations inmedicine, pharmacy and information technology. Mr. Bullard has over 30 yearsof health care industry experience.

Partners Rx Management, LLC is a member company of Diversified Health CareServices, Inc. (DHS), Phoenix, Ariz., which also includes ARG National (ARGN),a resource company for health insurance agencies; and Wholesale Benefits Club,Inc. (WBC), a discount card club for quality healthcare products and services.For additional information on Partners Rx, visit

SOURCE Partners Rx Management, LLC


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
The Lancet Publishes Major Phase 3 Study on Novel ...
Physical Therapist Provides Injury Analysis for Fa...